Stay updated on Nab-Sirolimus in Liver-Impaired Cancer Patients Clinical Trial
Sign up to get notified when there's something new on the Nab-Sirolimus in Liver-Impaired Cancer Patients Clinical Trial page.

Latest updates to the Nab-Sirolimus in Liver-Impaired Cancer Patients Clinical Trial page
- Check4 days agoChange DetectedA Locations section has been added listing Texas and Utah sites; the separate Texas Locations and Utah Locations pages have been removed, and the revision is updated to v3.3.3.SummaryDifference0.3%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check33 days agoChange DetectedThe page shows a revision update from v3.2.0 to v3.3.2; there are no visible changes to study details, eligibility criteria, or locations. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check40 days agoChange DetectedAdded metadata date fields to the Study Record Dates, including Last Update Posted (Estimated), with several future study dates listed. Removed a government funding status notice from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.8%

- Check55 days agoChange DetectedThe changes seem to be formatting/layout adjustments with no modification to core study details such as inclusion criteria, primary/secondary outcomes, or contacts. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check83 days agoChange DetectedNew operating-status notice and version update to v3.2.0; previous v3.1.0 version tag removed.SummaryDifference4%

- Check90 days agoChange DetectedUpdate: version upgraded to v3.1.0 and new contact details added (phone and three emails); previous version v3.0.2 removed.SummaryDifference0.1%

Stay in the know with updates to Nab-Sirolimus in Liver-Impaired Cancer Patients Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nab-Sirolimus in Liver-Impaired Cancer Patients Clinical Trial page.